Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
18.88
-0.33 (-1.72%)
Apr 30, 2026, 3:00 PM CST

SHA:600079 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
23,91825,38624,44522,27620,510
Other Revenue
43.7649.3679.8461.6738.69
23,96225,43524,52522,33820,549
Revenue Growth (YoY)
-5.79%3.71%9.79%8.71%-0.63%
Cost of Revenue
12,43514,12313,30212,63211,777
Gross Profit
11,52711,31211,2239,7068,772
Selling, General & Admin
6,1956,5636,1685,8275,327
Research & Development
1,5011,4711,462966.86810.47
Other Operating Expenses
212.6140.36202.61205.86224.56
Operating Expenses
7,9568,2997,9047,0576,411
Operating Income
3,5713,0143,3192,6492,361
Interest Expense
-271.04-351.37-354.14-476.57-602.15
Interest & Investment Income
127.63185.18265.56978.8365.38
Currency Exchange Gain (Loss)
-30.92-23.245.96123.67-58.34
Other Non Operating Income (Expenses)
-52.11-186.88-130.81120.33-59.2
EBT Excluding Unusual Items
3,3452,6373,1463,3952,007
Impairment of Goodwill
-332.06-206.98-26.15-35.33-42.68
Gain (Loss) on Sale of Investments
11.8250.08136.8543.427.89
Gain (Loss) on Sale of Assets
52.75-16.29-4.14-51.5126.06
Asset Writedown
-62.44-104.2-24.72-36.4-7.17
Other Unusual Items
41.4362.91156.13110.86182.16
Pretax Income
3,0562,4233,3843,4262,173
Income Tax Expense
564644.49568.56354.75354.78
Earnings From Continuing Operations
2,4921,7782,8153,0711,818
Minority Interest in Earnings
-637.12-448.6-680.78-587.19-501.05
Net Income
1,8551,3302,1342,4841,317
Net Income to Common
1,8551,3302,1342,4841,317
Net Income Growth
39.53%-37.70%-14.07%88.60%30.96%
Shares Outstanding (Basic)
1,6271,6221,6171,6131,587
Shares Outstanding (Diluted)
1,6271,6221,6291,6131,606
Shares Change (YoY)
0.36%-0.47%1.01%0.42%16.59%
EPS (Basic)
1.140.821.321.540.83
EPS (Diluted)
1.140.821.311.540.82
EPS Growth
39.02%-37.41%-14.94%87.81%12.33%
Free Cash Flow
1,7861,1438.93-672.27475.78
Free Cash Flow Per Share
1.100.700.01-0.420.30
Dividend Per Share
0.4800.4700.4600.1600.150
Dividend Growth
2.13%2.17%187.50%6.67%50.00%
Gross Margin
48.11%44.47%45.76%43.45%42.69%
Operating Margin
14.90%11.85%13.53%11.86%11.49%
Profit Margin
7.74%5.23%8.70%11.12%6.41%
Free Cash Flow Margin
7.45%4.50%0.04%-3.01%2.31%
EBITDA
4,5544,0154,1083,3723,020
EBITDA Margin
19.00%15.79%16.75%15.10%14.70%
D&A For EBITDA
982.641,002788.75723.08659.23
EBIT
3,5713,0143,3192,6492,361
EBIT Margin
14.90%11.85%13.53%11.86%11.49%
Effective Tax Rate
18.45%26.60%16.80%10.35%16.33%
Revenue as Reported
23,96225,43524,52522,33820,549
Source: S&P Global Market Intelligence. Standard template. Financial Sources.